SCHEMBL25484244

SCHEMBL25484244

Cc1ccc(C(C)C)c(OC2CCCC2)c1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
POLB P06746 1/20 0.44
ADRB2 P07550 1/20 0.43
SYK P43405 1/20 0.42
KDM4E B2RXH2 3/20 0.42
TSHR P16473 1/20 0.42
ATM Q13315 1/20 0.42
TRPA1 O75762 1/20 0.42
LMNA P02545 1/20 0.42
CHRM1 P11229 1/20 0.42
SLC6A2 P23975 1/20 0.42
ADRA1A P35348 1/20 0.42
HTR2B P41595 1/20 0.42
PDE4A P27815 1/20 0.40
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25484245 0.98 ALDH1A1 (0.46) ALDH1A1POLBADRB2SYKKDM4E
SCHEMBL25484242 0.93 SYK (0.44) ALDH1A1POLBADRB2SYKKDM4E
SCHEMBL25484248 0.80 SYK (0.50) ALDH1A1SYKKDM4ETSHRATM
SCHEMBL12794525 0.79 ADRB2 (0.48) ALDH1A1POLBADRB2SYKKDM4E
SCHEMBL8296638 0.77 ADRB2 (0.47) ALDH1A1POLBADRB2SYKKDM4E
SCHEMBL15077043 0.77 PDE4A (0.42) ALDH1A1ADRB2PDE4A
SCHEMBL23793611 0.77 PDE4A (0.53) PDE4APTGS1PTGS2
SCHEMBL25484521 0.76 PDE4A (0.52) PDE4APTGS1PTGS2
SCHEMBL1341690 0.76 SYK (0.44) ALDH1A1ADRB2SYKPDE4ATDP1
SCHEMBL22426537 0.76 CARM1 (0.43) ALDH1A1ADRB2PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265055-A1 STAT INIHIBITORY COMPOUNDS AND COMPOSITIONS OXFORD FINANCE LLC 2023-08-24 US disclosed
US-20230159445-A1 STAT INHIBITORY COMPOUNDS AND COMPOSITIONS OXFORD FINANCE LLC 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159445-A1 STAT INHIBITORY COMPOUNDS AND COMPOSITIONS STAT5A, STAT5B, STAT3 ALDH1A1 4241/4885POLB 2843/4885ADRB2 3558/4885
US-20230265055-A1 STAT INIHIBITORY COMPOUNDS AND COMPOSITIONS STAT5B, STAT5A, STAT3 ALDH1A1 3726/4885POLB 2923/4885ADRB2 3499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.